EURACTIV PR

An easy way of publishing your relevant EU press releases.

EuropaBio Statement on the vote on the ENVI Committee on the revision of the EU General Pharmaceutical Legislation

Date

19 Mar 2024

Sections

InfoSociety

Brussels, 19 March 2024 

EuropaBio takes note of today’s vote on the revision of the EU General Pharmaceutical Legislation  (GPL) in the European Parliament’s Committee on the Environment, Public Health and Food Safety  (ENVI). A supportive and future-proof GPL is essential to ensure Europe can fully benefit from  healthcare biotech innovations for patients, society, and economic development. 

As the co-legislators continue to progress on this critical legislation, EuropaBio is committed to work  with policymakers and all interested parties of the life sciences ecosystem. We remain convinced that  by bringing further improvements to the GPL, it can enable Europe to once again be a leader of  innovation. 

---------------
About EuropaBio 

EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology  industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of  life; to prevent, diagnose, treat, and cure diseases; to improve the quality and quantity of food and feedstuffs and to move  towards a biobased and zero-waste economy. EuropaBio represents corporate and associate members, plus national  biotechnology associations and bioregions. Read more about our work at www.europabio.org.
 

 

Jobs